Monitoring Fatigue In Daily Life In Adults With Cerebral Palsy or Acquired Brain Injury
NCT ID: NCT07135791
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
120 participants
OBSERVATIONAL
2025-03-26
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is: How do adults with CP and ABI experience fatigue in daily life?
Researchers will compare data from CP and ABI with healthy volunteers to see if they experience fatigue differently.
Participants will:
* Monitor their symptoms, mood, and behavior in real-time by completing a brief survey on their mobile phone 10 times a day for seven consecutive days.
* Attend a briefing session the day prior to the seven-day period of real-time monitoring.
* Wear an accelerometer for the seven-day period.
* Complete a daily sleep diary for the seven-day period.
* Receive feedback on their real-time monitoring data, sleep and activity data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enhancing Recovery in Non-Traumatic Spinal Cord Injury
NCT03320759
Spinal Cord Injury Energy Management Program
NCT01184365
Early Predictors for Neurological Outcome After Traumatic Spinal Cord Injury
NCT07210879
The Feasibility and Effects of Low-load Blood-flow Restricted Exercise Following Spinal Cord Injury
NCT03690700
Brain Monitoring, tDCS and Robotic Training in SCI
NCT06813287
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Qualitative research indicates that fatigue symptoms are dynamic and context-dependent, and the severity of symptoms can fluctuate throughout the day and from day to day.
People living with fatigue may tire more easily, in response to physical or mental exertion, than people without fatigue. Symptoms of fatigue may worsen dramatically and unexpectedly from one moment to the next. It can be very difficult for people to figure out, why they are suddenly overwhelmed by fatigue and to anticipate when symptoms will worsen again.
To help people manage their fatigue, assessment and treatment approaches need to encompass the daily fluctuations and their interaction over time with activities of daily living.
Ecological momentary assessment (EMA) is a well-established method for capturing everyday experiences, including thoughts and behaviors, in their immediate context. As they go about their everyday lives, respondents are prompted multiple times a day, on a mobile device, to answer a brief set of questions about their momentary, "here and now", experience, e.g., "how happy are you right now?". On traditional self-report instruments, such as questionnaires, rating scales, and diaries, respondents are required to recall information or report on their beliefs and attitudes, which introduce risks of bias to the assessment attributable to memory limitations, personal beliefs, and self-perception. By sampling everyday experiences in real-time, EMA reduces these biases and errors.
The longitudinal nature of EMA even allows for assessment of dynamic processes and interactions that occur over short periods of time. Such fine-grained data are crucial for understanding how and why symptoms change during the day and to identify circumstances that may worsen or mitigate fatigue. This may lead to better treatment and symptom management.
A few studies in CP and ABI have demonstrated the feasibility and prospect of using EMA to capture the dynamics of fatigue. However, evidence is scarce regarding factors of everyday life that exacerbate or mitigate fatigue, although this information is essential for effective management strategies. Qualitative research indicates that several potential triggers of fatigue may be similar across CP and ABI.
Primary Objective:
1. To identify patterns of fatigue and antecedents of symptom exacerbation in daily life of adults with CP and ABI.
Secondary Objectives:
2. To compare the dynamics of fatigue across CP, ABI, and neurotypical controls.
3. To identify factors in daily life that correlate with exacerbating fatigue symptoms.
4. To explore how physical activity, rest, and sleep influence fatigue patterns.
Design: We will use an intensive longitudinal observational study design. Participants will be asked to monitor in real-time for seven consecutive days. Notifications will pop up on their smartphone 10 times a day, and participants will be prompted to answer a brief survey about "how they are doing", "what they are doing", "where they are", and "who they are with", when they received the notification.
Participants will wear an accelerometer on their least affected thigh, and they will be asked to complete a sleep diary every morning in the seven-day period. The day prior to real-time monitoring, participants will meet with a research assistant to be instructed in the EMA protocol.
One week after real-time monitoring, participants will be invited to a feedback session, where the results of real-time monitoring of fatigue, activity, and sleep will be presented and discussed.
We will compare three groups of participants: Adults with CP, adults with ABI, and healthy volunteers without neurological conditions.
Participants with CP will be recruited via a public online announcement on the Elsass Foundation's website.
Participants with ABI will be recruited via two specialised brain injury rehabilitation centers (Vejlefjord Rehabilitering and Center for Rehabilitation of Brain Injury).
Healthy volunteers for the control group were initially planned to be recruited via the social network of the participants with CP or ABI. From August 2025, recruitment will be advertised publicly through social media platforms of the Neurorehabilitation Research and Knowledge Centre, Copenhagen University Hospital - Rigshospitalet (including newsletter, LinkedIn, and announcement on the webpage). The call for healthy volunteers will also be promoted through advocacy organizations for individuals with cerebral palsy or acquired brain injury, e.g., via social media platforms or their websites.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cerebral palsy
Adults with cerebral palsy
Real-time monitoring
Complete a brief 20-item survey 10 times a day for seven consecutive days, while wearing an accelerometer and completing daily sleep diaries.
Acquired brain injury
Adults with acquired brain injury
Real-time monitoring
Complete a brief 20-item survey 10 times a day for seven consecutive days, while wearing an accelerometer and completing daily sleep diaries.
Healthy volunteers
Adults without neurological conditions
Real-time monitoring
Complete a brief 20-item survey 10 times a day for seven consecutive days, while wearing an accelerometer and completing daily sleep diaries.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real-time monitoring
Complete a brief 20-item survey 10 times a day for seven consecutive days, while wearing an accelerometer and completing daily sleep diaries.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Speak, read, and write Danish
* Living in a private residence (i.e., not in institutional care or facilities providing 24-hour assistance)
* Able to walk independently or with assistive devices over short distances
* Able to operate a smartphone independently
* Self-reported diagnosis of CP
* Gross Motor Function Classification System (GMFCS) level ≤ II
* Communication Function Classification System level ≤ II
* Self-reported diagnosis of ABI, including stroke, traumatic brain injury, brain infections, toxins, anoxia, or encephalopathy (transient ischemic attack, concussion or post-concussion syndrome, intracranial tumors, or progressive brain diseases are not included)
* Between three months and two years post-injury
* modified Rankin Scale (mRS) score ≤ 3
Exclusion Criteria
* Current substance or alcohol abuse
* Night shift work or travel across time zones (1 to 3 zones within the last week or 4 to 6 zones within the last two weeks or at least 7 zones within the last 4 weeks)
30 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center for Rehabilitation of Brain Injury (Center for Hjerneskade)
UNKNOWN
Vejlefjord Rehabilitation
OTHER
Elsass Foundation
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frederik Dornonville de la Cour
Postdoc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Norup, Ph.D.
Role: STUDY_DIRECTOR
Neurorehabilitation Research and Knowledge Centre, Rigshospitalet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neurorehabilitation Research and Knowledge Centre, Rigshospitalet
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
p-2023-14839
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.